Skip to main content
Log in

Alteplase

Various toxicities: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Barrett CD, et al. MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study. Research and Practice in Thrombosis and Haemostasis 6: No. 2, Feb 2022. Available from: URL: http://doi.org/10.1002/rth2.12669

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alteplase. Reactions Weekly 1905, 29 (2022). https://doi.org/10.1007/s40278-022-14419-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-14419-5

Navigation